Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.
| Image |  |
|---|---|
| Description | scientific article published on 10 June 2016 |
| Author/s |
author: Tom Maishman Richard Wyn Griffiths Louise Stanton Penella Woll Christian H. Ottensmeier Matthew Wheater Edurne Arriola |
| Publication date | June 11, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |